GEN Exclusives – Animal Testing: Hard choices loom as Biosimilars boom

The approaching biosimilars tidal wave puts the question of animal testing for biologics further under scrutiny. Read our Chief Scientific Officer, Dr Daniel Galbraith’s article in GEN Exclusives.

Follow this link to read the full article.

For more detail on this issue, read our team’s position paper: Adventitious agent testing using in vivo protocols: A BioOutsource Position Paper 2014.

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.